Q2 2025 Performance Highlights - Reported revenue reached $168 billion[10] - Adjusted Earnings per share was $024[10] - Adjusted EBITDA margin was 166%[10] - Free cash flow amounted to $125 million[10] Q2 2025 Financial Results - Reported revenue was $1683 million[16] - Adjusted gross profit was $554 million, representing 329% of revenues[16] - Adjusted EBITDA was $280 million, representing 166% of revenues[16] - Adjusted operating income was $252 million, representing 150% of revenues[16] Q2 2025 Performance by Segment - Laboratory Solutions reported revenue of $1122 million with an organic growth of -1% and adjusted operating income of $133 million, resulting in an adjusted operating margin of 119%[19] - Bioscience Production reported revenue of $561 million with an organic growth of 2% and adjusted operating income of $140 million, resulting in an adjusted operating margin of 249%[19] 2025 Full-Year Guidance - The company anticipates organic growth between -2% and 0%[22]